| Certificate Name | Certificate University | Certificate Date |
|---|---|---|
| الدكتوراه في Pathology | The university of Nottingham | 15/12/2022 |
| الماجستير في Pathology | New York Medical college | 15/05/2016 |
| البكالوريوس في Laboratory medicine | Umm Alqurashi university | 24/07/2009 |
| Research Name | Research Date Submitted | Research Link |
|---|---|---|
| Myxovirus resistance 1 (MX1) is an independent predictor of poor outcome in invasive breast cancer. Br | 2020-06-01 12:00:00 AM | Myxovirus resistance 1 (MX1) is an independent predictor of poor outcome in invasive breast cancer. Br |
| Nucleolar protein 10 (NOP10) predicts poor prognosis in invasive breast cancer | Nucleolar protein 10 (NOP10) predicts poor prognosis in invasive breast cancer | |
| Upregulation of Cyclin B2 (CCNB2) in breast cancer contributes to the development of lymphovascular invasion | Upregulation of Cyclin B2 (CCNB2) in breast cancer contributes to the development of lymphovascular invasion | |
| The prognostic significance of interferon-stimulated gene 15 (ISG15) in invasive breast cancer | The prognostic significance of interferon-stimulated gene 15 (ISG15) in invasive breast cancer | |
| Clinicopathological significance of lipocalin 2 nuclear expression in invasive breast cancer | Clinicopathological significance of lipocalin 2 nuclear expression in invasive breast cancer | |
| A key genomic subtype associated with lymphovascular invasion in invasive breast cancer | A key genomic subtype associated with lymphovascular invasion in invasive breast cancer | |
| The prognostic significance of wild-type isocitrate dehydrogenase 2 (IDH2) in breast cancer | The prognostic significance of wild-type isocitrate dehydrogenase 2 (IDH2) in breast cancer | |
| The ITIM-Containing Receptor: Leukocyte-Associated Immunoglobulin-Like Receptor-1 (LAIR-1) Modulates Immune Response and Confers Poor Prognosis in Invasive Breast Carcinoma | The ITIM-Containing Receptor: Leukocyte-Associated Immunoglobulin-Like Receptor-1 (LAIR-1) Modulates Immune Response and Confers Poor Prognosis in Invasive Breast Carcinoma | |
| The clinical significance of cyclin B1 (CCNB1) in invasive breast cancer with emphasis on its contribution to lymphovascular invasion development | The clinical significance of cyclin B1 (CCNB1) in invasive breast cancer with emphasis on its contribution to lymphovascular invasion development |
| Place Name | Experince | From | To |
|---|
| Cource Name | place | Cource Date |
|---|
| Award/invention | Doner Place | Date |
|---|
| Committee Name | Committee Type | Join Date |
|---|
| CV File |
|---|